About Us
Research
People
Collaborations
Software & Services
Publications
News
Links
Photo Album
Contact Information
 
 

Publications


  • Hydropathic Analysis and Biological Evaluation of Stilbene Derivatives as Colchicine Site Microtubule Inhibitors with Anti-Leukemic Activity. A. Tripathi, D. Durrant, R.M. Lee, R. Baruchello, R. Romagnoli, D. Simoni and G.E. Kellogg, J. Enzyme Inhib. Med. Chem. (in press).
  • Web Application for Studying the Free Energy of Binding and Protonation States of Protein-Ligand Complexes Based on HINT. A.S. Bayden, M. Fornabaio, J.N. Scarsdale and G.E. Kellogg, J. Comp.-Aided Mol. Design (in press).
  • Comparative Docking Study of Anibamine as the First Natural Product CCR5 Antagonist in CCR5 Homology Models. G. Li, K.M. Haney, G.E. Kellogg and Y. Zhang, J. Chem. Inf. Model. 2009, 49, 120-132.
  • Design, Synthesis and Biological Evaluation of Novel Stilbene-Based Antitumor Agents. D. Simoni, F.P. Invidiata, M. Eleopra, P. Marchetti, R. Rondanin, R. Baruchello, G. Grisolia, A. Tripathi, G.E. Kellogg, D. Durrant and R.M. Lee, Bioorg. Med. Chem. 2009, 17, 512-522 .
  • Development of Water Soluble Derivatives of cis-3,4′,5-trimethoxy-3′-aminostilbene for Optimization and Use in Cancer Therapy. D.E. Durrant, J. Richards, A. Tripathi, G.E. Kellogg, P. Marchetti, M. Eleopra, G. Grisolia, D. Simoni and R.M. Lee, Invest. New Drugs 2009, 27, 41-52.
  • Target Flexibility: An Emerging Consideration in Drug Discovery and Design. P. Cozzini, G.E. Kellogg, F. Spyrakis, D.J. Abraham, G. Constantino, A. Emerson, F. Fanelli, H. Gohlke, L.A. Kuhn, G.M. Morris, M. Orozco, T.A. Perthinez, M. Rizzi and C.A. Sotriffer, J. Med. Chem. (Perspective) 2008, 51, 6237-6255.
  • Novel Inhibitors of Anthrax Edema Factor. D.L. Chen, M. Misra, L. Sower, J.W. Peterson, G.E. Kellogg and C.H. Schein, Bioorg. Med. Chem. 2008, 16, 7225-7233.
  • Energy-based prediction of amino acid-nucleotide base recognition. A. Marabotti, F. Spyrakis, A. Facchiano, P. Cozzini, S. Alberti, G.E. Kellogg and A. Mozzarelli, J. Comp. Chem. 2008, 29, 1955-1969.
  • Robust Classification of “Relevant” Water Molecules in Putative Protein Binding Sites. A. Amadasi, J.A. Surface, F. Spyrakis, P. Cozzini, A. Mozzarelli and G.E. Kellogg, J. Med. Chem. 2008, 51, 1063-1067.
  • Docking and Hydropathic Scoring of Polysubstituted Pyrrole Compounds with Anti-Tubulin Activity. A. Tripathi, M. Fornabaio, G.E. Kellogg, J.T. Gupton, D.A. Gewirtz, W.A. Yeudall, N.E. Vega and S.L. Mooberry, Bioorg. Med. Chem. 2008, 16, 2235-2242.
  • Stilbene derivatives that are colchicine site microtubule inhibitors have anti-leukemic activity and minimal systemic toxicity. T. M. Cao, D. Durrant, A. Tripathi, J. Liu, S. Tsai, G.E. Kellogg, D. Simoni and R.M. Lee, Am. J. Hematology 2008, 83, 390-397.
  • A LC–Electrospray Tandem MS Method for the Analysis of Naltrexone in Canine Plasma Employing a Molecular Model to Demonstrate the Absence of Internal Standard Deuterium Isotope Effects. S.S. Iyer, G.E. Kellogg and H.T. Karnes, J. Chromatog. Sci. 2007, 45, 694-700.
  • Hydrophopathic Analysis and Comparison of KcsA and Shaker Potassium Channels. Y. Peng, J.N. Scarsdale and G.E. Kellogg, Chem. Biodiv. 2007, 4, 2578-2592.
  • Complexity in Modeling and Understanding Protonation States: Computational Titration of HIV-1 Protease Inhibitor Complexes. A. Tripathi, M. Fornabaio, F. Spyrakis, A. Mozzarelli, P. Cozzini, and G.E. Kellogg, Chem. Biodiv. 2007, 4, 2564-2577.
  • Molecular Determinants of Antiviral Potency of Paramyxovirus Entry Inhibitors, M. Porotto, P. Carta, Y. Deng, G.E. Kellogg, M. Whitt, M. Lu, B.A. Mungall and A. Moscona, J. Virology 2007, 81, 10567-10574.
  • Tyrosine Nitration of IκBα: A novel mechanism for NF-κB Activation. V.A. Yakolev, I.J. Barani, C.S. Rabender, S.M. Black, J.K. Leach, P.R. Graves, G.E. Kellogg and R.B. Mikkelsen, Biochemistry 2007, 46, 11671-11683.
  • Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison. C.R. Arthur, J.T. Gupton, G.E. Kellogg, W.A. Yeudall, M.C. Cabot, I.F. Newsham and D.A. Gewirtz, Biochem. Pharmacol. 2007, 74, 981-991.
  • Molecular Modeling: Considerations for the Design of Pharmaceuticals and Biopharmaceuticals. P.D. Mosier and G.E. Kellogg, in “Biopharmaceutical Drug Design and Development: 2nd Edition”, S. Wu-Pong and Y. Rojanasakul, Eds., The Humana Press, Totowa, New Jersey, 2007, pp. 267-292.
  • Scoring Functions for Virtual Screening. F. Spyrakis, G.E. Kellogg, A. Amadasi and P. Cozzini, in “Frontiers in Drug Design and Discovery“, Bentham Science Publishers, Ltd. 2007, 3, 317-379.
  • The Consequences of Scoring Docked Ligand Conformations using Free Energy Correlations. F. Spyrakis, A. Amadasi, M. Fornabaio, D.J. Abraham, A. Mozzarelli, G.E. Kellogg and P. Cozzini, Eur. J. Med. Chem. 2007, 42, 921-933.
  • A Second Receptor Binding Site On The Human Parainfluenza 3 Hemagglutinin-Neuraminidase Contributes To Activation Of The Fusion Mechanism. M. Porotto, M. Fornabaio, G.E. Kellogg and A. Moscona, J. Virology 2007, 81, 3216-3228.
  • Energetics of the Protein-DNA-Water Interaction. F. Spyrakis, P. Cozzini, C. Bertoli, A. Marabotti, G.E. Kellogg and A. Mozzarelli, BMC Struct. Biol. 2007, 7, 4.
  • Inhibition of Hendra Virus Fusion. M. Porotto, L. Doctor, P. Carta, M. Fornabaio, O. Greengard, G.E. Kellogg and A. Moscona, J. Virology 2006, 80, 9837-9849.
  • Tools for Building a Comprehensive Modeling System for Virtual Screening Under Real Biological Conditions: The Computational Titration Algorithm, G.E. Kellogg, M. Fornabaio, D.L. Chen, D.J. Abraham, F. Spyrakis, P. Cozzini and A. Mozzarelli, J. Mol. Graph. Model. 2006, 24, 434-439.
  • Mapping the Energetics of Water-Protein and Water-Ligands Interactions by the HINT "Natural" Force Field: Predictive Tools for Characterizing the Roles of Water in Biomolecules. A. Amadasi, F. Spyrakis, P. Cozzini, D.J. Abraham, G.E. Kellogg and A. Mozzarelli, J. Mol. Biol. 2006, 358, 289-309.
  • Paramyxovirus Receptor-Binding Molecules: Engagement of One Site on the Hemagglutinin-Neuraminidase Modulates Activity at the Second Site. M. Porotto, M. Fornabaio, O. Greengard, M.T. Murrell, G.E. Kellogg and A. Moscona, J. Virology 2006, 80, 1204-1231.
  • Water: How to Evaluate its Contribution in Protein-Ligand Interactions. P. Cozzini, M. Fornabaio, A. Mozzarelli, F. Spyrakis, G.E. Kellogg and D.J. Abraham, Int. J. Quantum Chem. 2006, 106, 647-651.
  • A Molecular Model to Explain Paclitaxel and Docetaxel Sensitivity Changes through Adduct Formation with Primary Amines in Electrospray Ionization Mass Spectrometric Analysis. S.S. Iyer, S Gao, Z.-P. Zhang, G.E. Kellogg and H.T. Karnes, Rapid Comm. Mass Spectr. 2005, 19, 1221-1226.
  • A Computational Tool to Optimize Ligand Selectivity between Two Similar Biomacromolecular Targets. D.L. Chen and G.E. Kellogg, J. Comput.-Aided Mol. Design 2005, 19, 69-82.
  • New Application Design for a 3D Hydropathic Map-Based Search for Potential Water Molecules Bridging between Protein and Ligand. G.E. Kellogg, M. Fornabaio, D.L. Chen and D.J. Abraham, Internet Electr. J. Mol. Design 2005, 4, 194-209.
  • Homology Model of the CDK1/cyclin B Complex. C.F. McGrath, N. Pattabiraman, G.E. Kellogg, T. Lemcke, C. Kunick, E.A. Sausville, D.W. Zaharevitz and R. Gussio, J. Biomol. Struct. Dynamics 2005, 22, 493-502.
  • Free Energy of Ligand Binding to Protein: Evaluation of the Contribution of Water Molecules by Computational Methods. P. Cozzini, M. Fornabaio, A. Marabotti, D.J. Abraham, A. Mozzarelli and G.E. Kellogg, invited review for Curr. Med. Chem. 2004, 11, 3093-3118.
  • Computational Titration Analysis of a Multiprotic HIV-1 Protease-Ligand Complex. F. Spyrakis, M. Fornabaio, P. Cozzini, A. Mozzarelli, D.J. Abraham, and G.E. Kellogg, J. Am. Chem. Soc. 2004, 126, 11764-11765.
  • Evaluation of Deuterium Isotope Effects in Normal-Phase LC-MS-MS Separations Using a Molecular Modeling Approach. S.S. Iyer, Z.-P. Zhang, G.E. Kellogg, H.T. Karnes, J. Chromatog. Sci. 2004, 42, 383-387.
  • 1,2-Dithiole-3-ones as Potent Inhibitors of the Bacterial 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH). X. He, A.M. Reeve, U. Desai, G.E. Kellogg and K.A. Reynolds, Antimicrob. Agents Chemother. 2004, 48, 3093-3102.
  • Simple, Intuitive Calculations of Free Energy of Binding for Protein-Ligand Complexes. 3. The Free Energy Contribution of Structural Waters Molecules in HIV-1 Protease Complexes. M. Fornabaio, F. Spyrakis, A. Mozzarelli, P. Cozzini, D.J. Abraham and G.E. Kellogg, J. Med. Chem. 2004, 47, 4507-4516.
  • Getting It Right. Modeling of pH, Solvent and "Nearly" Everything Else in Virtual Screening of Biological Targets. G.E. Kellogg, M. Fornabaio, F. Spyrakis, A. Lodola, P. Cozzini, A. Mozzarelli and D.J. Abraham, J. Mol. Graph. Model. 2004, 22, 479-486.
  • A Computational Model for Anthracycline Binding to DNA: Tuning Groove-Binding Intercalators for Specific Sequences. D.J. Cashman and G.E. Kellogg, J. Med. Chem. 2004, 47, 1360-1374.
  • The Importance of Being Exhaustive. Optimization of Bridging Structural Water Molecules and Water Networks in Models of Biological Systems. G.E. Kellogg and D. Chen, Chem. Biodiver. 2004, 1, 98-105.
  • Docking and Hydropathic Analysis of Hoechst 33258 with Double-Stranded RNA. D.J. Cashman, J.P. Rife and G.E. Kellogg, Med. Chem. Res.. 2003, 12, 445-456.
  • Validation of Poisson-Boltzmann Electrostatic Potential Fields in 3D QSAR: A CoMFA Study on Multiple Data Sets. G.E. Kellogg, S. Phatak, A. Nicholls and J.A. Grant, QSAR Combinatorial Sci. 2003, 22, 959-964.
  • Simple, Intuitive Calculations of Free Energy of Binding for Protein-Ligand Complexes. 2. Computational Titration and pH Effects in Molecular Models of Neuraminidase and Inhibitors, M. Fornabaio, P. Cozzini, D.J. Abraham, A. Mozzarelli and G.E. Kellogg, J. Med. Chem. 2003, 46, 4487-4500.
  • Hydropathic Analysis of the Free Energy Differences in Anthracycline Antibiotic Binding to DNA. D.J. Cashman, J.N. Scarsdale and G.E. Kellogg, Nucl. Acids Res. 2003, 31, 4410-4416.
  • 3D QSAR in Drug Discovery. G.E. Kellogg and S.F. Semus, in “Modern Methods of Drug Discovery”, R. Hilgenfeld and A. Hillisch, Eds., Birkhäuser Verlag AG, Basel, Switzerland, 2002, pp. 223-241.
  • Irreversible Inhibition of CYP2D6 by (-)-Chloroephedrine, a Possible Impurity in Methamphetamine. B. Rege, K. Carter, M. Sarkar, G.E. Kellogg and W. Soine, Drug Metab. Disposition 2002, 30, 1337-1343.
  • Transport and Structural Studies of Sulfonated Styrene-Ethylene Copolymer Membranes. J.M. Serpico, S.G. Ehrenberg, J.J. Fontanella, X. Jiao, D. Perahia, K.A. McGrady, E.H. Sanders, G.E. Kellogg and G.E. Wnek, Macromolecules 2002, 35, 5916-5921.
  • Simple, Intuitive Calculations of Free Energy of Binding for Protein-Ligand Complexes. 1. Models Without Explicit Constrained Water, P. Cozzini, M. Fornabaio, A. Marabotti, D.J. Abraham, G.E. Kellogg and A. Mozzarelli, J. Med. Chem. 2002, 45, 2469-2483.
  • Very Empirical Treatment of Solvation and Entropy Effects. A Force Field Derived from LogP. G.E. Kellogg, J.C. Burnett and D.J. Abraham, Perspectives: J. Computer-Aided. Mol. Design 2001, 15, 381-393.
  • Which Aminoglycoside Ring is Most Important for Binding? A Hydropathic Analysis of Gentamicin, Paromomycin and Analogs. D.J. Cashman, J.P. Rife and G.E. Kellogg, Bioorg. Med. Chem. Lett. 2001, 11, 119-122.
  • Computationally Accessible Method for Estimating Free Energy Changes Resulting from Site Specific Mutations of Biomolecules. Systematic Modeling Building and Structural/Hydropathic Analysis of Deoxy and Oxy Hemoglobins. J.C. Burnett, P. Botti, D.J. Abraham and G.E. Kellogg, Proteins: Str. Funct. Genet. 2001, 42, 355-377.
  • HINT Predictive Analysis of Binding Between Retinol Binding Protein and Hydrophobic Ligands. A. Marabotti, L. Balestreri, P. Cozzini, A. Mozzarelli, G.E. Kellogg and D.J. Abraham, Bioorg. Med. Chem. Lett. 2000, 10, 2129-2132.
  • Hydrophobicity. Is LogPo/w More than the Sum of Its Parts? G.E. Kellogg and D.J. Abraham, Eur. J. Med. Chem. 2000, 35, 651-661.
  • Structure-Based Design Modifications of the Paullone Molecular Scaffold for Cyclin-Dependent Kinase Inhibition. R. Gussio, D.W. Zaharevitz, C.F. McGrath, N. Pattabiraman, G.E. Kellogg, C. Schultz, A. Linke, C. Kunick, M. Loest, L. Meijer and E.A. Sausville, Anti-Cancer Drug Des. 2000, 15, 53-66.
  • Computational Methodology for Estimating Changes in Free Energies of Biomolecular Association Upon Mutation. The Importance of Bound Water in Dimer-Tetramer Assembly of b37W Mutant Hemoglobins. J.C. Burnett, G.E. Kellogg and D.J. Abraham, Biochemistry 2000, 39, 1622-1633.
  • Ligand Docking and Scoring in DNA Oligonucleotides. Binding of Doxorubicin and Modeled Analogues to Optimize Sequence Specificity. G.E. Kellogg, D.J. Cashman and J.N. Scarsdale, Med. Chem. Res. 1999, 9, 592-603.
  • Discovery of Novel HIV-1 Reverse Transcriptase Inhibitors using a Combination of 3D Database Searching and 3D QSAR. D.W. Zaharevitz, R. Gussio, A. Wiegand, R. Jalluri, N. Pattabiraman, G.E. Kellogg, L.A. Pallansch, S.S. Yang and R.W. Buckheit, Jr., Med. Chem. Res. 1999, 9, 551-564.
  • Guest Editorial: Ligand Docking and Scoring: New Techniques and Applications in Drug Discovery. G.E. Kellogg, Med. Chem. Res. 1999, 9, 439-444.
  • Development of Empirical Biomolecular Interaction Models that Incorporate Hydrophobicity and Hydropathy. The HINT Paradigm. G.E. Kellogg and D.J. Abraham, Analusis, 1999, 27, 19-22.
  • Identification and Hydropathic Characterization of Structural Features Affecting Sequence Specificity for Doxorubicin Intercalation into DNA Double-Stranded Polynucleotides. G.E. Kellogg, J.N. Scarsdale, and F.A. Fornari, Jr., Nucl. Acids Res., 1998, 26, 4721-4732.
  • Utilization of a 3D QSAR Methodology for Data Mining the National Cancer Institute Repository of Small Molecules in Application to HIV-1 Reverse Transcriptase Inhibition. R. Gussio, N. Pattabiraman, G.E. Kellogg, D.W. Zaharevitz, Methods 1998, 14, 255-263.
  • Finding Optimum Field Descriptors for 3D QSAR. G.E. Kellogg, Med. Chem. Res. 1997, 7, 417-427.
  • Effects of Entropy on QSAR Equations for HIV-1 Protease: 1. Using Hydropathic Binding Descriptors. 2. Unrestrained Complex Structure Optimizations. G.E. Kellogg, D.T. Wei, and J.C. Meadows, Med. Chem. Res. 1997, 7, 259-270.
  • Hydropathic Analysis of the Noncovalent Interactions between Molecular Subunits of Structurally-Characterized Hemoglobins. D.J. Abraham, G.E. Kellogg, J.M. Holt, and G.K. Ackers, J. Mol. Bio. 1997, 272, 613-632.
  • C5aR Ligand Peptide 3D QSAR Study Performed with an Applied Linear Conformation. C. Anderson, G.E. Kellogg, and R.J. Freer, J. Peptide Res. 1997, 49, 476-483.
  • The E-State Fields. Applications to 3D QSAR. G.E. Kellogg, L.B. Kier, P. Gaillard, and L.H. Hall, J. Computer-Aided Mol. Design, 1996, 10, 513-520..
  • Polymeric Coordination Complexes Bridging Molecular Metals and Conductive Polymers. G.E. Kellogg and J.G. Gaudiello, in "Inorganic Materials, 2nd Edition", D.W. Bruce and D. O'Hare, eds., J. Wiley and Sons, Chichester, 1996, pp. 378-428.
  • Differences in Hydropathic Properties of Ligand Binding at Four Independent Sites in Wheat Germ Agglutinin-Oligosaccharide Crystal Complexes. C.S. Wright and G.E. Kellogg, J. Prot. Sci., 1996, 5, 1466-1476.
  • All-Atom Models for the Non-nucleoside Binding Site of HIV-1 Reverse Transcriptase Complexed with Inhibitors: A 3D QSAR Approach. R. Gussio, N. Pattabiraman, D.W. Zaharevitz, G.E. Kellogg, I. Topol, W.G. Rice, C.A. Schaeffer, J.W. Erickson, and S.K. Burt, J. Med. Chem. 1996, 39, 1645-1650.
  • Evaluating Docked Complexes with the HINT Exponential Function and Empirical Atomic Hydrophobicities. E.C. Meng, I.D. Kuntz, D.J. Abraham, and G.E. Kellogg, J. Computer-Aided Mol. Design 1994, 8, 299-306.
  • Cyclodextrin - Barbiturate Inclusion Complexes: A CoMFA/HINT 3-D QSAR Study. V.R. Nayak and G.E. Kellogg, Med. Chem. Res. 1994, 3, 491-502.
  • The Effect of Physical Organic Properties on Hydrophobic Fields. D.J. Abraham and G.E. Kellogg, J. Computer-Aided Mol. Design (Symposium Proceedings: 1993 Meeting of the Molecular Graphics Society) 1994, 8, 41-49.
  • Effect of Distamycin on Chlorambucil-Induced Mutagenesis in pZ189: Evidence of a Role for Minor Groove Alkylation at Adenine N-3. P. Wang, G.B. Bauer, G.E. Kellogg, D.J. Abraham, and L.F. Povirk, Mutagenesis 1994, 9, 133-139.
  • Hydrophobic Fields. D.J. Abraham and G.E. Kellogg, in "3D QSAR in Drug Design, Theory, Methods and Applications", H. Kubinyi, ed., ESCOM Sciences Publishers BV, Leiden, 1993, pp. 506-522.
  • KEY, LOCK, and LOCKSMITH. Complementary Hydrophobicity Map Predictions of Drug Structure from a Known Receptor/Receptor Structure from Known Drugs. G.E. Kellogg and D.J. Abraham, J. Mol. Graph. 1992, 10, 212-217.
  • Polymeric Coordination Complexes Bridging Molecular Metals and Conductive Polymers. G.E. Kellogg and J.G. Gaudiello, in "Inorganic Materials", D.W. Bruce and D. O'Hare, eds., J. Wiley and Sons, Chichester, 1992, pp. 355-407.
  • New Tools for Modeling and Understanding Hydrophobicity and Hydrophobic Interactions. G.E. Kellogg, G.S. Joshi, and D.J. Abraham, Med. Chem. Res. 1992, 1, 444-453.
  • HINT - A New Method of Empirical Hydrophobic Field Calculation for CoMFA. G.E. Kellogg, S.F. Semus, and D.J. Abraham, J. Computer-Aided Mol. Design 1991, 5, 545-552.
  • Allosteric Modifiers of Hemoglobin. 2. Crystallographically Determined Binding Sites and Hydrophobic Binding/Interaction Analysis of Novel Hemoglobin Oxygen Effectors. F.C. Wireko, G.E. Kellogg, and D.J. Abraham, J. Med. Chem. 1991, 34, 758-767.
  • Molecular Metals with Widely Tunable Band Filling. Response of the Collective Properties of a Phthalocyanine Molecular Metal to Drastic Excursions in Partial Oxidation and Charge-Compensating Counterions. M. Almeida, J.G. Gaudiello, G.E. Kellogg, S.M. Tetrick, H.O. Marcy, W.J. McCarthy, J.C. Butler, C.R. Kannewurf, and T.J. Marks, J. Am. Chem. Soc. 1989, 111, 5271-5284.
  • Molecular Metals with Widely Tunable Band Filling. Structure/Stoichiometry/ Counterion Relationships in the Electrochemistry of a Cofacially Joined Polymeric Phthalocyanine Metal. J.G. Gaudiello, G.E. Kellogg, S.M. Tetrick, and T.J. Marks, J. Am. Chem. Soc. 1989, 111, 5259-5271.
  • Relative Strengths of Early Transition Metal M-H and M-C Bonds in Substituted Niobocenes and Tantalocenes. Thermodynamic Trends and Electronic Factors of Olefin Insertion into a Metal-Hydride Bond. D.L. Lichtenberger, G.P. Darsey, G.E. Kellogg, R.D. Sanner, V.G. Young, Jr., and J.R. Clark, J. Am. Chem. Soc. 1989, 111, 5019-5028.
  • Electrochemistry of Cofacial Phthalocyanine Polymers: What Can We Learn About How Molecular Metal Collective Properties Respond to Wide Variations in Band Filling? G.E. Kellogg, J.G. Gaudiello, J.A. Schlueter, S.M. Tetrick, T.J. Marks, H.O. Marcy, W.J. McCarthy, and C.R. Kannewurf, in "Proceedings of the International Conference on Science and Technology of Synthetic Metals", Synth. Metals 1989, 29, F15-F24.
  • Characterization of Metal Complex Positive Ions in the Gas Phase by Photoelectron Spectroscopy. D.L. Lichtenberger and G.E. Kellogg, in "Gas Phase Inorganic Chemistry", D.H. Russell, ed., Modern Inorganic Chemistry Series, Plenum, New York, 1989, pp. 245-277.
  • Routes to Molecular Metals with Widely Variable Counterions and Band-Filling. Electrochemistry of a Conductive Organic Polymer with an Inorganic Backbone. T.J. Marks, J.G. Gaudiello, G.E. Kellogg, and S.M. Tetrick, in "Inorganic and Organometallic Polymers", M. Zeldin, K.J. Wynne, and H.R. Allcock, eds. A.C.S. Symposium Series, Volume 360, Washington, 1987, pp. 224-237.
  • Photoelectron Spectroscopy: Experimental Characterization of Electronic Structure and Bonding in Organometallic Molecules. D.L. Lichtenberger, G.E. Kellogg, and L.S.K. Pang, in "Experimental Organometallic Chemistry: A Practicum in Synthesis and Characterization", A.L. Wayda and M.Y. Darensbourg, eds. A.C.S. Symposium Series, Volume 357, Washington, 1987, pp. 265-289.
  • Experimental Quantum Chemistry. The Photoelectron Spectroscopy of Organotransition Metal Complexes. D.L. Lichtenberger and G.E. Kellogg, Acc. Chem. Res. 1987, 20, 379-387.
  • Localization Effects in the Auger Spectra of Ring Nitrogen Systems: Pyridine, Poly(2-vinyl)pyridine, Borazine, and Boron Nitride. R.R. Rye, J.A. Kelber, G.E. Kellogg, K.W. Nebesny, and D.L. Lichtenberger, J. Chem. Phys. 1987, 86, 4375-4383.
  • Inexpensive and High-Precision Digital Power Supply and Counting Interface for UPS, XPS, and Auger Spectrometers. D.L. Lichtenberger, G.E. Kellogg, J.G. Kristofzski, D. Page, S. Turner, G. Klinger, and J. Lorenzen, Rev. Sci. Instrum. 1986, 57, 2366.
  • Electronic Structure Factors of Carbon-Hydrogen Bond Activation. The Photoelectron Spectroscopy of Cyclohexenylmanganese Tricarbonyl. D.L. Lichtenberger and G.E. Kellogg, J. Am. Chem. Soc. 1986, 108, 2560-2567.
  • Principles of Electronic Structure in Transition Metal Complexes. Additive Ligand Electronic Effects and Core-Valence Ionization Correlations for Mo(CO)6-n(PMe3)n where n = 0, 1, 2, 3. D.L. Lichtenberger, G.E. Kellogg, and G.H. Landis, J. Chem. Phys. 1985, 83, 2759-2768.
  • Ligand Additivity in the Valence Photoelectron Spectroscopy of Phosphine-Substituted Molybdenum Carbonyls. B.E. Bursten, D.J. Darensbourg, G.E. Kellogg, and D.L. Lichtenberger, Inorg. Chem. 1984, 23, 4361-4365.
  • Electronic Structure and Bonding Characteristics of Cyclopentadienyl d Metal-Ligand Complexes. Core and Valence Ionization Study of CpM(CO)2 where M = Co and Rh and Cp = η5-C5H5 and η5-C5(CH3)5. D.L. Lichtenberger, D.C. Calabro, and G.E. Kellogg, Organometallics 1984, 3, 1623-1630.